GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $155,731 | $1,218,396 | $944,242 | $944,242 |
| - Cash | $68,097 | $31,446 | $95,068 | $25,916 |
| + Debt | $80,482 | $66,077 | $18,898 | $1,572 |
| Enterprise Value | $168,116 | $1,253,027 | $868,072 | $919,898 |
| Revenue | $6,384 | $0 | $962 | $3,001 |
| % Growth | – | -100% | -67.9% | – |
| Gross Profit | $6,384 | $0 | $962 | $3,001 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$153,989 | -$102,749 | -$50,447 | -$27,649 |
| % Margin | -2,412.1% | – | -5,244% | -921.3% |
| Net Income | -$167,055 | -$114,729 | -$54,279 | -$28,966 |
| % Margin | -2,616.8% | – | -5,642.3% | -965.2% |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.3 |
| % Growth | -36.6% | -66.1% | -86.7% | – |
| Operating Cash Flow | -$136,731 | -$91,832 | -$46,599 | -$25,636 |
| Capital Expenditures | -$26,547 | -$15,148 | -$10,047 | -$1,896 |
| Free Cash Flow | -$163,278 | -$106,980 | -$56,646 | -$27,532 |